Global Biochip (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Market to reach $5.6 Billion by 2015 http://www.marketsandmarkets.com/Market-Reports/biochips-advanced-technologiesand-global-market-54.html
The “Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)” analyzes the biochip market by types and applications and studies the major market drivers, restraints, opportunities, and market trends for biochip market in North America, Europe, Asia, and Rest of the World. Browse market data tables and in-depth TOC on "Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (20102015)”.
http://www.marketsandmarkets.com/Market-Reports/biochips-advanced-technologiesand-global-market-54.html Early buyers will receive 10% customization of reports.
Biochips were developed and commercialized in the eighties. Since then, market has offered tremendous growth and hence seen an influx of players vying fiercely for a share of this market. The global biochips market is studied by the types and key applications. It was valued at $2.6 billion in 2010 and is expected to reach $5.6 Billion by 2015; growing at a CAGR of 16.7%.Major players in this market include Affymetrix, Inc. (U.S.), Illumnia, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Roche NimbleGen (U.S.), Sequenom Inc, (U.S.), Luminex Corporation (U.S.), Bio-Rad Laboratories (U.S.), Biacore Life Sciences by GE Healthcare (Sweden), EMD Millipore (U.S.), Life Technologies (U.S.), Perkin Elmer (U.S.), Caliper Life Sciences (U.S.), Fluidigm Corporation (U.S.), Cepheid (U.S.), Epoch Biosciences (U.S.), US Biomax (U.S.), Sigma Aldrich (U.S.), Biochain Institute, Inc. (U.S.), Origene (U.S.), Super BioChips (South Korea ), and IsuAbxis Co Ltd (Seoul, Korea). Buy Now: http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=54
“New product launches” and “agreements and collaborations” are the two main strategies adopted by the players to stay competitive in this market. The major applications in the market driving its growth in future include cancer diagnosis and treatment, expression profiling, and diagnostics since early detection of disease and targeted treatment options are still the unmet need of this market. There were 12.3 million new cases of cancer worldwide in 2007 and about 7.6 million deaths. These figures are estimated to rise up to 16 million new cancer diagnoses and about 10 million deaths by 2020 according to WHO & American Cancer Society. Free sample PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=54
About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact Us Mr. Rohan North - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252 Tel: +1-888-6006-441 Email: firstname.lastname@example.org MarketsandMarkets Blog http://www.marketsandmarkets.com http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets
Published on Feb 6, 2014
[250 Pages Report] Global Biochips Market Research Report categorizes on the basis of applications, types, and geography; forecasting revenu...